BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20539091)

  • 41. Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.
    Papasavvas E; Azzoni L; Pistilli M; Hancock A; Reynolds G; Gallo C; Ondercin J; Kostman JR; Mounzer K; Shull J; Montaner LJ
    AIDS; 2008 Jun; 22(10):1153-61. PubMed ID: 18525261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
    Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
    AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.
    De Milito A; Aleman S; Marenzi R; Sonnerborg A; Fuchs D; Zazzi M; Chiodi F
    Clin Exp Immunol; 2002 Mar; 127(3):486-94. PubMed ID: 11966765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.
    Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivière Y; Warszawski J; Rouzioux C; Buseyne F
    J Infect Dis; 2012 May; 205(10):1520-8. PubMed ID: 22427678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brief Report: Youth Living With Perinatally Acquired HIV Have Lower Physical Activity Levels as They Age Compared With HIV-Exposed Uninfected Youth.
    Dirajlal-Fargo S; Williams PL; Broadwell C; McFarland EJ; Powis KM; Jacobson DL; Jao J;
    J Acquir Immune Defic Syndr; 2021 May; 87(1):700-705. PubMed ID: 33443964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    Kapetanovic S; Giganti MJ; Abzug MJ; Lindsey JC; Sirois PA; Montepiedra G; Canniff J; Agwu A; Boivin MJ; Weinberg A;
    AIDS; 2021 Jul; 35(9):1375-1384. PubMed ID: 33710019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurodevelopmental Outcomes in Preschool and School Aged Children With Biliary Atresia and Their Native Liver.
    Squires JE; Ng VL; Hawthorne K; Henn LL; Sorensen LG; Fredericks EM; Alonso EM; Murray KF; Loomes KM; Karpen SJ; Cavallo LA; Molleston JP; Bezerra JA; Rosenthal P; Squires RH; Wang KS; Schwarz KB; Arnon R; Magee JC; Sokol RJ;
    J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):79-86. PubMed ID: 31503218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
    Banerjee T; Pensi T; Banerjee D; Grover G
    Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surrogate markers for disease progression in treated HIV infection.
    Ghani AC; de Wolf F; Ferguson NM; Donnelly CA; Coutinho R; Miedema F; Goudsmit J; Anderson RM
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):226-31. PubMed ID: 11694828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
    Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children.
    Wilkinson JD; Williams PL; Yu W; Colan SD; Mendez A; Zachariah JPV; Van Dyke RB; Shearer WT; Margossian RE; Lipshultz SE;
    AIDS; 2018 Jun; 32(10):1267-1277. PubMed ID: 29596110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men.
    Lake JE; Vo QT; Jacobson LP; Sacktor N; Miller EN; Post WS; Becker JT; Palella FJ; Ragin A; Martin E; Munro CA; Brown TT
    Antivir Ther; 2015; 20(2):235-44. PubMed ID: 25810377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy.
    de Gaetano Donati K; Rabagliati R; Tumbarello M; Tacconelli E; Amore C; Cauda R; Lacoviello L
    AIDS; 2003 Mar; 17(5):765-8. PubMed ID: 12646805
    [No Abstract]   [Full Text] [Related]  

  • 55. Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
    Thiébaut R; Chêne G; Jacqmin-Gadda H; Morlat P; Mercié P; Dupon M; Neau D; Ramaroson H; Dabis F; Salamon R;
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):380-6. PubMed ID: 12843750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Childhood Blood Lead Levels With Cognitive Function and Socioeconomic Status at Age 38 Years and With IQ Change and Socioeconomic Mobility Between Childhood and Adulthood.
    Reuben A; Caspi A; Belsky DW; Broadbent J; Harrington H; Sugden K; Houts RM; Ramrakha S; Poulton R; Moffitt TE
    JAMA; 2017 Mar; 317(12):1244-1251. PubMed ID: 28350927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.
    Muenchhoff M; Healy M; Singh R; Roider J; Groll A; Kindra C; Sibaya T; Moonsamy A; McGregor C; Phan MQ; Palma A; Kloverpris H; Leslie A; Bobat R; LaRussa P; Ndung'u T; Goulder P; Sobieszczyk ME; Archary M
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):46-55. PubMed ID: 28670966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homeostatic role of IL-7 in HIV-1 infected children on HAART: association with immunological and virological parameters.
    Resino S; Galán I; Correa R; Pajuelo L; Bellón JM; Muñoz-Fernández MA
    Acta Paediatr; 2005 Feb; 94(2):170-7. PubMed ID: 15981750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-positive youth who are perinatally infected have impaired endothelial function.
    Dirajlal-Fargo S; Sattar A; Kulkarni M; Bowman E; Funderburg N; McComsey GA
    AIDS; 2017 Sep; 31(14):1917-1924. PubMed ID: 28590332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.